课题基金 / 基金详情

Improving identification and healthcare for patients with Inherited Cancer Syndromes: Evidence-based EMR implementation using a web-based computer platform

Improving identification and healthcare for patients with Inherited Cancer Syndromes: Evidence-based EMR implementation using a web-based computer platform
改善遗传性癌症综合征患者的识别和医疗保健:使用基于网络的计算机平台实施基于证据的 EMR
批准号:
10831647
负责人:
Lori Ann Orlando
金额:
$10.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-01 至 2024-08-31
关键词:
AddressAdministrative SupplementAffectAlgorithmsCaringCharacteristicsClinicalCollaborationsCommunitiesComputerized Medical RecordComputersDataData CollectionData ElementDiseaseDoctor of PhilosophyEarly identificationElectronic Medical Records and Genomics NetworkElectronicsElementsEndocrinologyEnrollmentEnsureEquipment and supply inventoriesEquityExclusionExposure toFamilyFamily health statusFeedbackFrightFutureGenderGender IdentityGeneticGenetic CounselingGenomeGenomicsGoalsGuidelinesHealthHealthcareHealthcare SystemsHereditary Malignant NeoplasmHereditary Neoplastic SyndromesHormonalIndividualInheritedInterceptIntersexInterventionInterviewKnowledgeLeadMalignant NeoplasmsMammary Gland ParenchymaMastectomyMeasuresMedicalMedical RecordsModelingOnline SystemsOrganOutcomeParticipantPatient CarePatientsPersonal SatisfactionPhenotypic SexPilot ProjectsPopulationPopulation HeterogeneityProceduresProcessPublishingQualitative ResearchRecommendationRecording of previous eventsReduce health disparitiesResearchResearch PersonnelResidual stateRiskRisk AssessmentSex CharacteristicsSexual and Gender MinoritiesStructureStudentsSyndromeSystemTestingTissuesTrainingTreesUpdateWorkassessment applicationcancer carecancer riskcareerclinical applicationclinical carecommunity engagementcultural competencedata modelingdata qualitydesignearly onsetevidence baseexperiencefallsgender diversitygender minority groupgenetic pedigreegenetic risk assessmentgenomic datagenotypic sexhormone therapyimprovedinformation gatheringinsightinterestlifetime riskmarginalized communitymarginalized populationmembermodel developmentnonbinaryoutreachparent grantphase 4 studypreventprogramspsychosocialreproductive developmentresearch studyresponsescreeningsexsex assigned at birthsex development disordertherapy designtooltransgender

项目摘要

项目成果

Lori Ann Orlando的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT Hereditary cancers are prevalent and cause high lifetime risk of cancer. Early identification of at-risk individuals is imperative to prevent and intercept cancer, but hereditary cancer risk screening lags behind guidelines - a care gap that is wider for medically marginalized communities. Transgender, gender diverse, and sex diverse (TGSD) patients represent one such marginalized community who could benefit from better cancer care, including hereditary cancer risk screening. Phenotypic sex, chromosomal sex, current and past organ/tissue inventory, and hormonal milieu impact risk assessment and care for hereditary cancer syndromes. These elements have unique implications for TGSD individuals. While electronic apps represent an important strategy to reduce health disparities by systematizing risk assessment, these apps collect sex-related variables that are used in risk calculations; culturally incompetent, and thus inaccurate, collection of this data could cause participants to receive an incorrect risk assessment result, ultimately impacting downstream care. The parent grant of the proposed project, the Family History and Cancer Risk Study (FOREST), has implemented a risk assessment app, called MeTree, to increase systematization of risk assessment. MeTree collects sex- and gender-related data, and the sex-related data element drives risk assessment result return. However, following preliminary implementation of Me Tree with just over 300 participant responses, we have found inconsistency of the interpretation of the sex-related field among TGSD individuals, leading to sex-related responses that, based on medical record review, do not correspond with expected response domains for this question. This is likely due to question and response wording and options. Very few measures have been designed with community engagement of TGSD individuals, and no such measures have been designed for genetic risk assessment. We propose engagement with TGSD participants and community members to integrate participant feedback directly into a redesign of the Me Tree sex- and gender-related questions and response options. In semi-structured qualitative interviews with TGSD FOREST participants exposed to MeTree, we will seek to understand participant interpretations of these questions, data validity, and collect participant ideas for respectful and accurate redesign. Using rapid initial analyses of these interviews, we will incorporate changes into a new model for presentation in community engagement panels with panelists who have not been exposed to Me Tree within the study. In these panels, we will engage in co-design with TGSD community members to generate a final Me Tree model that respectfully and accurately collects elements needed for risk assessment. The entire research study will be led by transgender researchers, giving them a unique relational perspective that will facilitate addressing cisnormative assumptions present in current sex- and gender-related data models. Final analyses will be published, and changes incorporated into the MeTree app.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Conducting inclusive research in genetics for transgender, gender-diverse, and sex-diverse individuals: Case analyses and recommendations from a clinical genomics study.
对跨性别、性别多样化和性别多样化个体进行遗传学包容性研究:临床基因组学研究的案例分析和建议。
DOI: 10.1002/jgc4.1785
发表时间: 2023
期刊: Journal of genetic counseling
影响因子: 1.9
作者: [Bland,HarrisT, Gilmore,MarianJ, Andujar,Justin, Martin,MakennaA, Celaya-Cobbs,Natasha, Edwards,Clasherrol, Gerhart,Meredith, Hooker,GillianW, Kraft,StephanieA, Marshall,DanaR, Orlando,LoriA, Paul,NatalieA, Pratap,Siddharth, Rosenbloom]
通讯作者: Rosenbloom
IGNITE Cost Extension - Year 6
  • 批准号:
    10821184
  • 项目类别:
  • 资助金额:
    $118.86万
  • 财政年份:
    2023
  • 负责人:
    Lori Ann Orlando
  • 依托单位:
Building and Deploying a Genomic-Medicine Risk Assessment Model for Diverse Primary Care Populations.
  • 批准号:
    10630415
  • 项目类别:
  • 资助金额:
    $81.27万
  • 财政年份:
    2022
  • 负责人:
    Lori Ann Orlando
  • 依托单位:
Deploying a genomic-medicine risk assessment model for diverse primary care populations and settings
  • 批准号:
    10470752
  • 项目类别:
  • 资助金额:
    $72.15万
  • 财政年份:
    2021
  • 负责人:
    Lori Ann Orlando
  • 依托单位:
Deploying a genomic-medicine risk assessment model for diverse primary care populations and settings
  • 批准号:
    10227463
  • 项目类别:
  • 资助金额:
    $75.97万
  • 财政年份:
    2021
  • 负责人:
    Lori Ann Orlando
  • 依托单位:
海外基金